Atrial fibrillation of new onset during acute illness: prevalence of, and risk factors for persistence after hospital discharge
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Atrial fibrillation (AF) of new onset during acute illness (AFNOAI) has a variable incidence of 1%–44% in hospitalized patients. This study assesses the risk factors for persistence of AFNOAI in the 5 years after hospital discharge for critically ill patients. Methods This was a retrospective cohort study. All patients ≥18 years old admitted to the medical intensive care unit (MICU) of a tertiary care hospital from January 1, 2012, to October 31, 2015, were screened. Those designated with AF for the first time during the hospital admission were included. Risk factors for persistent AFNOAI were assessed using a Cox’s proportional hazards model. Results Two-hundred and fifty-one (1.8%) of 13,983 unique MICU admissions had AFNOAI. After exclusions, 108 patients remained. Forty-one patients (38%) had persistence of AFNOAI. Age (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.01–1.08), hyperlipidemia (HR, 2.27; 95% CI, 1.02–5.05) and immunosuppression (HR, 2.29; 95% CI, 1.02–5.16) were associated with AFNOAI persistence. Diastolic dysfunction (HR, 1.46; 95% CI, 0.71–3.00) and mitral regurgitation (HR, 2.00; 95% CI, 0.91–4.37) also showed a trend towards association with AFNOAI persistence. Conclusions Our study showed that AFNOAI has a high rate of persistence after discharge and that certain comorbid and cardiac factors may increase the risk of persistence. Anticoagulation should be considered, based on a patient’s individual AFNOAI persistence risk.
Abstract
Background Atrial fibrillation (AF) of new onset during acute illness (AFNOAI) has a variable incidence of 1%–44% in hospitalized patients. This study assesses the risk factors for persistence of AFNOAI in the 5 years after hospital discharge for critically ill patients. Methods This was a retrospective cohort study. All patients ≥18 years old admitted to the medical intensive care unit (MICU) of a tertiary care hospital from January 1, 2012, to October 31, 2015, were screened. Those designated with AF for the first time during the hospital admission were included. Risk factors for persistent AFNOAI were assessed using a Cox’s proportional hazards model. Results Two-hundred and fifty-one (1.8%) of 13,983 unique MICU admissions had AFNOAI. After exclusions, 108 patients remained. Forty-one patients (38%) had persistence of AFNOAI. Age (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.01–1.08), hyperlipidemia (HR, 2.27; 95% CI, 1.02–5.05) and immunosuppression (HR, 2.29; 95% CI, 1.02–5.16) were associated with AFNOAI persistence. Diastolic dysfunction (HR, 1.46; 95% CI, 0.71–3.00) and mitral regurgitation (HR, 2.00; 95% CI, 0.91–4.37) also showed a trend towards association with AFNOAI persistence. Conclusions Our study showed that AFNOAI has a high rate of persistence after discharge and that certain comorbid and cardiac factors may increase the risk of persistence. Anticoagulation should be considered, based on a patient’s individual AFNOAI persistence risk.
참고문헌 (10)
- McIntyre WF, "Atrial fibrillation detected initially during acute medical illness : a systematic review", Eur Heart J Acute Cardiovasc Care, 8, pp.130~141 (2019)
- Wetterslev M, "New-onset atrial fibrillation in adult critically ill patients : a scoping review", Intensive Care Med, 45, pp.928~938 (2019)
- Hyun J, "Natural course of new-onset postoperative atrial fibrillation after noncardiac surgery", J Am Heart Assoc, 10, pp.e018548~ (2021)
- Andrade J, "The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms", Circ Res, 114, pp.1453~1468 (2014)
- Kotecha D, "Heart failure with preserved ejection fraction and atrial fibrillation : vicious twins", J Am Coll Cardiol, 68, pp.2217~2228 (2016)
- Kavousi M, "Differences in epidemiology and risk factors for atrial fibrillation between women and men", Front Cardiovasc Med, 7, pp.3~ (2020)
- Walkey AJ, "Long-term outcomes following development of new-onset atrial fibrillation during sepsis", Chest, 146, pp.1187~1195 (2014)
- Aibar J, "New-onset atrial fibrillation in sepsis : a narrative review", Semin Thromb Hemost, 47, pp.18~25 (2021)
- Moss TJ, "New-onset atrial fibrillation in the critically ill", Crit Care Med, 45, pp.790~797 (2017)
- Xiao FP, "Outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review and meta-analysis of 225,841 patients", Am J Emerg Med, 42, pp.23~30 (2021)
